A roundtable of experts discusses injection site sarcomas in Part 1 of this Clinician’s Forum overview. The experts include Sarah Boston, DVM, DVSc, DADVS; Audra Fenimore, DVM,DACVM; Shannon Vawter, DVM, MS and Nancy Welborn, DVM.
Source: Clinician’s Brief, May 2016.
KEY POINTS
- The most recent studies suggest that in the genetically predisposed cat the injection of many substances may contribute to sarcoma development.
- It is difficult to assess increased risk for sarcoma formation in susceptible cats among different types of injectables.
- Chronic inflammation at the site of injection is speculated as one contributory factor, but cause and effect have not been established.
- Heredity may be a factor in determining risk for these sarcomas.
INSIGHTS: This forum is sponsored by a grant from Boehringer-Ingelheim Vetmedica, Inc.